We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DB:NYSEDeutsche Bank AG Analysis

Data as of 2026-08-08 - not real-time

$38.06

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At $38.06, Deutsche Bank Aktiengesellschaft shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 10.7%. Relative strength is 63.8 — approaching overbought — and the MACD signal is bullish. Watch $33.87 as support and $38.39 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 10.0 sits below the sector average of 16.9. Analyst price targets sit 6.4% above the current price. Revenue is growing at 8.7% on a 22.7% profit margin. The 3.06% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 34.9%, a beta of 1.62 and a maximum drawdown of 29.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

Key Points Interested in Deutsche Bank Aktiengesellschaft?The European banking sector is facing a re-rating this year, led by a “higher for longer” interest rate environment...Detailed price information for Deutsche Bank Ag DB-N from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Trading above the 200-day average of 34.75
  • MACD momentum is positive
  • 30-day price change of +10.7%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 10.0 versus sector average of 16.9
  • Trading above the 200-day average of 34.75
  • Analyst targets imply +6.4% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 10.0 versus sector average of 16.9
  • Analyst targets imply +6.4% versus the current price
  • Profit margin of 22.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth8.70%
Profit Margin22.72%
P/E Ratio10.0
ROE8.89%
ROA0.49%
P/B Ratio0.8
Op. Cash Flow$-17728000000
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI63.8
Support$33.87
Resistance$38.39
MA 20$36.08
MA 50$34.73
MA 200$34.75
MACDBullish
VolumeStable
Fear & Greed Index94.82

Valuation

Target Price$40.50
Upside/Downside6.41%
GradeUndervalued
TypeValue
Dividend Yield3.06%

Risk Assessment

Beta1.62
Volatility34.86%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.